Blakeley, Jaishri <br/><br/>
Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannoma.  [electronic resource] 

 -  Current opinion in otolaryngology & head and neck surgery  Oct 2012 
 - 372-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1531-6998 
<br/><br/><label>Standard No.: </label>10.1097/MOO.0b013e328357d2ee  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Clinical Trials as Topic<br/>Female<br/>Follow-Up Studies<br/>Forecasting<br/>Humans<br/>Male<br/>Molecular Targeted Therapy--methods<br/>Neovascularization, Pathologic--prevention & control<br/>Neurofibromatosis 2--drug therapy<br/>Neurofibromin 2--drug effects<br/>Neuroma, Acoustic--drug therapy<br/>Risk Assessment<br/>TOR Serine-Threonine Kinases--drug effects<br/>Treatment Outcome